Clinical Trials Logo

Filter by:
NCT ID: NCT04417647 Completed - Wound Heal Clinical Trials

G-Wound (VZ for Wound Treatment)

Start date: June 5, 2020
Phase: N/A
Study type: Interventional

This is a prospective, randomized, open-label, controlled, exploratory trial that aims to investigate the local skin tolerability of topically administered VZ and to evaluate efficacy and safety parameters associated with improved wound condition and healing

NCT ID: NCT04413760 Completed - Clinical trials for Work-Related Musculoskeletal Disorders

Physiological and Psychological Strain in Elementary School Teacher

BelaPrim
Start date: November 13, 2018
Phase:
Study type: Observational

Survey will enquire the physical and psychological conditions in primary school teachers in Upper Austria. All primary teachers of the 553 Upper Austrian elementary schools (approximately 5105 persons) will be interviewed between November 2018 and April 2019. The main outcomes will be Musculoskeletal pains in nine body regions, the physical activity and the psychological stress with the "Work-related Behaviour and Experience Patterns" and big five personality traits.

NCT ID: NCT04400578 Completed - Clinical trials for Cervical Intraepithelial Neoplasia Grade 2

TRICIN: Prospective Study on the Efficacy of Single Topical Trichloroacetic Acid (TCA) 85% in the Treatment of Cervical Intraepithelial Neoplasia (CIN 1/2)

TRICIN
Start date: February 7, 2020
Phase: N/A
Study type: Interventional

Trichloroacetic acid 85% =TCA is an investigational device intended to achieve a complete histologic remission in individuals with cervical intraepithelial neoplasia (CIN) grade 1/2. The device system is to be used only in accordance with the approved Investigational Plan on subjects, who have given written informed consent. High remission and regression rates are expected after a single topical treatment with 85% TCA. After a single topical treatment with 85% TCA for CIN 1-2 (Expected 70% or higher; null hypothesis: not higher than 55%). Regression is defined as improvement from high grade lesion (CIN 2) at baseline to low grade lesion (CIN 1) after TCA treatment. Regression from CIN 1 normal squamous epithelium after the TCA treatment is equal to remission and will be counted as a remission in combined analysis. Remission is defined as complete histologic remission of CIN back to normal squamous epithelium after the TCA treatment, i.e., no cervical dysplasia is detectable by histology or cytology after the TCA treatment. Type-specific HPV Clearance is defined as disappearance of the HPV type detected at screening.

NCT ID: NCT04399668 Completed - Endometriosis Clinical Trials

Comparison of Ultrasound-determined and Intraoperative #Enzian-classification in Patients With Deep Endometriosis

Start date: January 1, 2020
Phase:
Study type: Observational

The Enzian classification, which was developed in order to describe deep endometriotic (DE) lesions, is determined intraoperatively by the surgeon. Transvaginal ultrasound (TVS) examination is considered as the first-line imaging technique for endometriosis. The aim of this study is to compare the assessment of presence and severity grade of endometriotic lesions in different #Enzian compartments by a preoperative ultrasound examination to the definitive intraoperative Enzian classification using the latest revision of the Enzian classification (#Enzian).

NCT ID: NCT04391517 Completed - Anemia Clinical Trials

SpHb Perioperatively

Start date: January 1, 2020
Phase: N/A
Study type: Interventional

This study's goal is to establish SpHb threshold values that can help health care provider sort out which patients would potentially benefit from central laboratory Hb testing pre-operatively and who would likely not. It also aims to compare the mean difference between these two methods in a pre-operative setting. SpHb values will be observed and recorded from patients meeting the inclusion criteria undergoing pre-operative evaluation for plastic, trauma, orthopaedic, urological, general and gynaecological surgery over one year by the Department of Anaesthesiology and Intensive Care Medicine at the University Medical Centre Graz. All patients will be evaluated pre-operatively by an anaesthesiologist, utilizing both central laboratory measurements as clinical routine and non-invasive Hb measurements. Both measurements (SpHb and central laboratory Hb) will be documented, along with the normally collected patient data, using the electronic system currently in use. Median values from the two methods will be compared, and possible cut-off values calculated.

NCT ID: NCT04386148 Completed - Clinical trials for Anastomotic Leak Rectum

Impact of Obsidian ® ASG on Anastomotic Healing

Start date: June 1, 2018
Phase:
Study type: Observational

The use of regenerative medicine in colorectal surgery constitutes an entirely new therapeutic principle. The aim of this new therapeutic approach is to reduce the anastomotic leak rate and minimise morbidity and mortality. The literature identifies the leak rate for colorectal operations as 3-39%.

NCT ID: NCT04383366 Completed - Keratoconus Clinical Trials

Agreement and Accuracy of Different Devices Corneal Measurements

Start date: October 21, 2019
Phase:
Study type: Observational

To compare repeatability, reproducibility and agreement of both, AS- OCT and Scheimpflug imaging, for the measurement of corneal curvature and corneal thickness in patients with keratoconus.

NCT ID: NCT04375293 Completed - Chronic Rhinitis Clinical Trials

Characterisation of the Nasal Microbiome in Patients With N-ERD

MicroNERD
Start date: January 7, 2020
Phase: N/A
Study type: Interventional

Chronic rhinosinusitis (CRS) with (w) and without (s) nasal polyps (NP) in its different shapes is currently affecting up to 16% of the total population of the United States and around 11% of the population in Europe. It may also be associated with a hypersensitivity to non-steroidal anti-inflammatory (NSAID) drugs in a syndrome called NSAID-exacerbated respiratory disease (N-ERD) characterized by highly recurrent polyps and concomitant asthma. The pathophysiological mechanisms especially with regards to the potential role of the microbiome in driving N-ERD are so far not fully understood. Here, the investigators plan to analyse the nasal microbiome in these patients and to compare it to nasal samples from CRSwNP and CRSsNP patients as well as healthy controls (in total 80 subjects). This will provide insights into potential differences in the microbiome as compared to other CRS patients and the impact of the microbiome in driving this disease.

NCT ID: NCT04369365 Completed - COVID Clinical Trials

A Single-blinded, Randomized, Placebo Controlled Phase II Trial of Prophylactic Treatment With Oral Azithromycin Versus Placebo in Cancer Patients Undergoing Antineoplastic Treatment During the Corona Virus Disease 19 (COVID-19) Pandemic

Start date: April 27, 2020
Phase: Phase 2
Study type: Interventional

Prophylactic treatment in cancer patients undergoing antineoplastic therapy during the COVID-19 pandemic.

NCT ID: NCT04359173 Completed - Clinical trials for Delayed Graft Function

Propensity Score Matched Comparison of HMP vs. SCS in Kidney Transplantation

HMP
Start date: August 1, 2015
Phase:
Study type: Observational

Hypothermic machine perfusion (HMP) is considered superior to static cold storage (SCS) in kidney transplantation, but the true benefit in the real-world experience remains incompletely understood. The aim of our study is to investigate the real-world impact of HMP on kidney graft function after deceased donor kidney transplant in an HMP cohort propensity score matched with SCS. Propensity score matching will be based on CIT, ECD, gender mismatch, CMV mismatch, re-TX and ET-senior program with a caliper of 0.05